| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Balancing hormonal shifts: exploring the impact of ageing and dietary restriction
|
Twigg, Stephen M
|
|
|
11 |
12 |
p. 884-886
|
article
|
| 2 |
Catecholamine-induced hypertensive crises: current insights and management
|
Nazari, Matthew A
|
|
|
11 |
12 |
p. 942-954
|
article
|
| 3 |
Challenges in implementing nationwide epidemiological studies on metabolic non-communicable diseases in low-income and middle-income countries
|
Anjana, Ranjit Mohan
|
|
|
11 |
12 |
p. 889-891
|
article
|
| 4 |
Chronicling insulin from discovery to crisis
|
Burki, Talha
|
|
|
11 |
12 |
p. 900
|
article
|
| 5 |
Comparing the effectiveness of glucose-lowering agents: real-world data to emulate a four-arm target trial
|
Ahmed, Ali
|
|
|
11 |
12 |
p. 892-894
|
article
|
| 6 |
Comparing the effectiveness of glucose-lowering agents: real-world data to emulate a four-arm target trial
|
Vural Keskinler, Mirac
|
|
|
11 |
12 |
p. 894
|
article
|
| 7 |
Comparing the effectiveness of glucose-lowering agents: real-world data to emulate a four-arm target trial
|
Ceriello, Antonio
|
|
|
11 |
12 |
p. 894-895
|
article
|
| 8 |
Comparing the effectiveness of glucose-lowering agents: real-world data to emulate a four-arm target trial – Authors' reply
|
Xie, Yan
|
|
|
11 |
12 |
p. 895-896
|
article
|
| 9 |
Correction to Lancet Diabetes Endocrinol 2023; 11: 720–30
|
|
|
|
11 |
12 |
p. e14
|
article
|
| 10 |
C-peptide and metabolic outcomes in trials of disease modifying therapy in new-onset type 1 diabetes: an individual participant meta-analysis
|
Taylor, Peter N
|
|
|
11 |
12 |
p. 915-925
|
article
|
| 11 |
Diabetes: knowing your risk matters
|
The Lancet Diabetes & Endocrinology,
|
|
|
11 |
12 |
p. 879
|
article
|
| 12 |
Empagliflozin in adults hospitalised with COVID-19: a (null) hypothesis for RECOVERY
|
Garofolo, Monia
|
|
|
11 |
12 |
p. 880-881
|
article
|
| 13 |
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
|
|
|
|
11 |
12 |
p. 905-914
|
article
|
| 14 |
Glycaemic fluctuations across the menstrual cycle: possible effect of the brain
|
Hummel, Julia
|
|
|
11 |
12 |
p. 883-884
|
article
|
| 15 |
Impact of disease-modifying therapy on β-cell function and metabolic control in newly diagnosed type 1 diabetes
|
Knip, Mikael
|
|
|
11 |
12 |
p. 881-882
|
article
|
| 16 |
Iodine status in Iran: from deficient to replete
|
Azizi, Fereidoun
|
|
|
11 |
12 |
p. 903-904
|
article
|
| 17 |
Making adjustments: diabetes and developmental disability
|
Burki, Talha
|
|
|
11 |
12 |
p. 901-902
|
article
|
| 18 |
Metabolic non-communicable diseases in India: time to act
|
Nag, Shikha
|
|
|
11 |
12 |
p. 896-897
|
article
|
| 19 |
Metabolic non-communicable diseases in India: time to act
|
Habeeb, Shifa
|
|
|
11 |
12 |
p. 897-898
|
article
|
| 20 |
Metabolic non-communicable diseases in India: time to act – Authors' reply
|
Anjana, Ranjit Mohan
|
|
|
11 |
12 |
p. 898-899
|
article
|
| 21 |
Sex steroids and the female brain across the lifespan: insights into risk of depression and Alzheimer's disease
|
Barth, Claudia
|
|
|
11 |
12 |
p. 926-941
|
article
|
| 22 |
Tackling the diabetes surge in sub-Saharan Africa through novel youth-centric strategies
|
Chilunga, Felix P
|
|
|
11 |
12 |
p. 886-889
|
article
|
Journal description